rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1998-11-13
|
pubmed:abstractText |
Activated lymphocytes are considered to play a pathogenic role in Crohn's disease (CD) and ulcerative colitis (UC), although only a limited fraction of the gut-residing lymphocytes in these diseases may be pathogenetically involved, due to active recruitment from the peripheral circulation. Our aim was to characterize in situ preactivated lymphocytes in inflammatory bowel disease mucosa by expansion with interleukin-2.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0036-5521
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
743-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9712239-Biological Markers,
pubmed-meshheading:9712239-Biopsy, Needle,
pubmed-meshheading:9712239-CD4-Positive T-Lymphocytes,
pubmed-meshheading:9712239-CD8-Positive T-Lymphocytes,
pubmed-meshheading:9712239-Cell Adhesion Molecules,
pubmed-meshheading:9712239-Colitis, Ulcerative,
pubmed-meshheading:9712239-Crohn Disease,
pubmed-meshheading:9712239-Female,
pubmed-meshheading:9712239-Flow Cytometry,
pubmed-meshheading:9712239-Humans,
pubmed-meshheading:9712239-Interleukin-2,
pubmed-meshheading:9712239-Intestinal Mucosa,
pubmed-meshheading:9712239-Lymphocyte Activation,
pubmed-meshheading:9712239-Male,
pubmed-meshheading:9712239-Reference Values,
pubmed-meshheading:9712239-Sensitivity and Specificity
|
pubmed:year |
1998
|
pubmed:articleTitle |
Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis.
|
pubmed:affiliation |
Dept. of Rheumatology, Pathology, and Gastroenterology, University Hospital Ghent, Belgium.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|